Stockscreener 앱 받기
25.10
1.50%
0.37
시장 영업 전:
25.19
0.09
+0.36%
Moderna Inc 주식(MRNA)의 최신 뉴스
Moderna, Inc. (MRNA) Expands Into Oncology with Pan-Tumor Vaccine - Yahoo Finance
Earnings visualization tools for Moderna Inc.Weekly Profit Analysis & Reliable Entry Point Trade Alerts - Newser
Credit Agricole S A Decreases Position in Moderna, Inc. $MRNA - MarketBeat
Candriam S.C.A. Decreases Position in Moderna, Inc. $MRNA - MarketBeat
Moderna, Inc. $MRNA Shares Sold by Aberdeen Group plc - MarketBeat
Moderna, Inc. $MRNA Shares Sold by Russell Investments Group Ltd. - MarketBeat
Wellington Management Group LLP Cuts Stake in Moderna, Inc. $MRNA - MarketBeat
Volume spikes in Moderna Inc. stock – what they meanMarket Activity Summary & Fast Moving Market Watchlists - Newser
Jump Financial LLC Has $25.58 Million Stock Position in Moderna, Inc. $MRNA - MarketBeat
Hsbc Holdings PLC Has $17.91 Million Holdings in Moderna, Inc. $MRNA - MarketBeat
Comparing Moderna Inc. in custom built stock radarsMarket Movers & High Accuracy Buy Signal Tips - Newser
Korea Investment CORP Boosts Stake in Moderna, Inc. $MRNA - MarketBeat
Cresset Asset Management LLC Buys Shares of 18,420 Moderna, Inc. $MRNA - MarketBeat
FDA approves COVID-19 vaccines only for ‘high risk’ people - Yahoo News Australia
Which COVID-19 vaccines are FDA approved in US? - Reuters
FDA Curbs Covid Shot Access as RFK Jr. Takes Tougher Stance - Bloomberg.com
Moderna to Present at Upcoming Conferences in September 2025 - Canton Repository
RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines - Benzinga
FDA approves updated COVID boosters, but narrows use - BioPharma Dive
Why Moderna (MRNA) Stock Is Up Today - TradingView
Moderna Receives US FDA Approval for Updated COVID-19 Vaccines Targeting the LP.8.1 Variant - MarketScreener
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2 - The Joplin Globe
Latest COVID Defense: Moderna's New LP.8.1 Vaccines Cover 4M Annual Cases, FDA Gives Green Light - Stock Titan
FDA approves updated Covid vaccines, including mRNA shots from Pfizer, Moderna - Endpoints News
FDA authorizes updated Covid-19 shots, but with restrictions - Seeking Alpha
F.D.A. Approves Covid Shots With New Restrictions - The New York Times
Moderna (NASDAQ:MRNA) Stock Price Down 5.2% Following Analyst Downgrade - MarketBeat
Moderna Challenged on Bid to Shift Covid-Shot Patent Costs to US - Bloomberg Law News
Stock Analysis | Moderna OutlookA Deep Dive Into Mixed Signals and Key Catalysts - AInvest
Groupe la Francaise Has $284,000 Stake in Moderna, Inc. $MRNA - MarketBeat
Northern Trust Corp Buys 160,572 Shares of Moderna, Inc. $MRNA - MarketBeat
Moderna, Inc. $MRNA Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Sells 183,308 Shares of Moderna, Inc. $MRNA - MarketBeat
Developing predictive dashboards with Moderna Inc. dataMarket Volume Report & AI Optimized Trading Strategy Guides - Newser
UK Court of Appeal Confirms Moderna’s EP’949 Patent is Valid and Infringed by Pfizer/BioNTech - Corpus Christi Caller-Times
Short interest data insights for Moderna Inc.July 2025 Opening Moves & Entry and Exit Point Strategies - Newser
Will breakout in Moderna Inc. lead to full recovery2025 Support & Resistance & Growth Focused Investment Plans - Newser
Moderna Inc. stock retracement – recovery analysis2025 Trading Recap & Intraday High Probability Setup Alerts - Newser
Moderna, Inc. shares fall 2.37% intraday amid political uncertainty and Fed independence concerns. - AInvest
Market reaction to Moderna Inc.’s recent newsDollar Strength & Long-Term Growth Portfolio Plans - Newser
Untreated Metastatic or Unresectable Melanoma Clinical Trial Pipeline Expands as 10+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight - GlobeNewswire Inc.
Using RSI to spot recovery in Moderna Inc.July 2025 Opening Moves & Pattern Based Trade Signal System - Newser
Moderna stock falls, Pfizer dips on COVID vaccine ban speculation - Investing.com
Contra Guys: This revolutionary biotech pioneer has joined our watchlist - The Globe and Mail
Moderna Inc. stock momentum explainedRisk Management & Free High Accuracy Swing Entry Alerts - Newser
What’s the recovery path for long term holders of Moderna Inc.2025 Macro Impact & Low Risk Entry Point Tips - Newser
Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' - Benzinga
0.98%
8.06%
자본화:
|
볼륨(24시간):